Blocking RANKL/RANK interaction by recombinant OPG or anti-RANKL neutralizing antibodies significantly decreases proliferation and increases apoptosis, suggesting that the stimulatory effect of RANKL on the growth of cervical cancer cells may be mainly dependent on membrane RANKL/RANK interaction [66]. Here, TNFRSF11A is linked to cervical carcinoma.